Kasvu Therapeutics Oy
3367901-3ActiveDeveloping novel small molecule drugs targeting TrkB for brain disorders.
Drug Development Companykasvutx.com
Overview
- Unknown
- Employees
- Unknown
- Revenue
- 2023
- Founded
Key Decision Makers
Eero Castrén
Co-founder, Board member Professor, Research Director
Rafael Moliner
Co-founder, Biology Lead
Giray Enkavi
Co-founder, Principal Scientist Modeling
Matti Karvonen
Chief Medical Officer
+5 more contacts in Funnelfeedr
Description
Kasvu is a drug development company focused on harnessing the power of neuroplasticity to address major global mental health challenges. They specialize in creating first and best-in-class small molecule neuroplastogens designed to treat conditions involving altered neuronal connectivity. Their prim...
ScandiBio Therapeutics AB